{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T04:09:37Z","timestamp":1783742977778,"version":"3.55.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T00:00:00Z","timestamp":1700784000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T00:00:00Z","timestamp":1700784000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br Dent J"],"published-print":{"date-parts":[[2023,11,24]]},"DOI":"10.1038\/s41415-023-6447-8","type":"journal-article","created":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T09:03:01Z","timestamp":1700816581000},"page":"783-788","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Pre-existing medication-related osteonecrosis of the jaw before dental extraction"],"prefix":"10.1038","volume":"235","author":[{"given":"Mariam","family":"Al-Sarraj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,24]]},"reference":[{"key":"6447_CR4993","unstructured":"Scottish Dental Clinical Effectiveness Programme. Oral Health Management of Patients at Risk of Medication-related Osteonecrosis of the Jaw. 2017. Available at https:\/\/www.sdcep.org.uk\/published-guidance\/medication-related-osteonecrosis-of-the-jaw\/ (accessed October 2023)."},{"key":"6447_CR5003","doi-asserted-by":"crossref","unstructured":"Coleman R, Body J J, Aapro M, Hadji P, Herrstedt J. Bone health in cancer patients: ESMO Clinical Practice Guidelines. Ann Oncol 2014; 25: 124-137.","DOI":"10.1093\/annonc\/mdu103"},{"key":"6447_CR5007","doi-asserted-by":"crossref","unstructured":"Ruggiero S L, Dodson T B, Aghaloo T, Carlson E R, Ward B B, Kademani D. American Association of Oral and Maxillofacial Surgeons' Position Paper on Medication-Related Osteonecrosis of the Jaws - 2022 Update. J Oral Maxillofac Surg 2022; 80: 920-943.","DOI":"10.1016\/j.joms.2022.02.008"},{"key":"6447_CR5013","doi-asserted-by":"crossref","unstructured":"Bhula S, Mallya S, Tetradis S. The role of imaging in MRONJ: An evidence based, institutional experience. Oral Surg Oral Med Oral Pathol Oral Radiol 2020; 130: 58-59.","DOI":"10.1016\/j.oooo.2020.03.009"},{"key":"6447_CR5017","doi-asserted-by":"crossref","unstructured":"Marx R E. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 2003; 61: 1115-1117.","DOI":"10.1016\/S0278-2391(03)00720-1"},{"key":"6447_CR5023","unstructured":"European Medicines Agency. Xgeva: Summary of product characteristics. Available at https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/xgeva-epar-product-information_en.pdf (accessed March 2023)."},{"key":"6447_CR5027","unstructured":"European Medicines Agency. Zometa: Summary of product characteristics. Available at https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/zometa-epar-product-information_en.pdf (accessed March 2023)."},{"key":"6447_CR5031","unstructured":"Royal College of Physicians. Medication-related osteonecrosis of the jaw: guidance for the oncology multidisciplinary team. 2019. Available at https:\/\/www.rcplondon.ac.uk\/guidelines-policy\/medication-related-osteonecrosis-jaw-guidance-oncology-multidisciplinary-team (accessed March 2023)."},{"key":"6447_CR5035","doi-asserted-by":"crossref","unstructured":"Ikesue H, Doi K, Morimoto M et al. Switching from zoledronic acid to denosumab increases the risk for developing medication-related osteonecrosis of the jaw in patients with bone metastases. Cancer Chemother Pharmacol 2021; 87: 871-877.","DOI":"10.1007\/s00280-021-04262-w"},{"key":"6447_CR5040","doi-asserted-by":"crossref","unstructured":"Ehrenstein V, Heide-J\u00f8rgensen U, Schi\u00f8dt M et al. Osteonecrosis of the jaw among patients with cancer treated with denosumab or zoledronic acid: results of a regulator-mandated cohort postauthorization safety study in Denmark, Norway, and Sweden. Cancer 2021 127: 4050-4058.","DOI":"10.1002\/cncr.33802"},{"key":"6447_CR5044","doi-asserted-by":"crossref","unstructured":"McGowan K, McGowan T, Ivanovski S. Risk factors for medication-related osteonecrosis of the jaws: A systematic review. Oral Dis 2018; 24: 527-536.","DOI":"10.1111\/odi.12708"},{"key":"6447_CR5052","doi-asserted-by":"crossref","unstructured":"Nicolatou-Galitis O, Schi\u00f8dt M, Mendes R A et al. Medication-related osteonecrosis of the jaw: definition and best practice for prevention, diagnosis, and treatment. Oral Surg Oral Med Oral Pathol Oral Radiol 2019; 127: 117-135.","DOI":"10.1016\/j.oooo.2018.09.008"},{"key":"6447_CR5060","doi-asserted-by":"crossref","unstructured":"Kamimura M, Taguchi A, Komatsu M et al. Long waiting time before tooth extraction may increase delayed wound healing in elderly Japanese. Osteoporos Int 2018; 30: 621-628.","DOI":"10.1007\/s00198-018-4775-3"},{"key":"6447_CR5066","doi-asserted-by":"crossref","unstructured":"Chang J, Hakam A E, McCauley L K. Current Understanding of the Pathophysiology of Osteonecrosis of the Jaw. Curr Osteoporos Rep 2018; 16: 584-595.","DOI":"10.1007\/s11914-018-0474-4"},{"key":"6447_CR5070","doi-asserted-by":"crossref","unstructured":"Barasch A, Cunha-Cruz J, Curro F A et al. Risk factors for osteonecrosis of the jaws: a case-control study from the CONDOR dental PBRN. J Dent Res 2011; 90: 439-444.","DOI":"10.1177\/0022034510397196"},{"key":"6447_CR5074","doi-asserted-by":"crossref","unstructured":"Otto S, Pautke C, Martin Jurado O et al. Further development of the MRONJ minipig large animal model. J Craniomaxillofac Surg 2017; 45: 1503-1514.","DOI":"10.1016\/j.jcms.2017.07.002"},{"key":"6447_CR5078","doi-asserted-by":"crossref","unstructured":"Bolette A, Lecloux G, Rompen E, Albert A, Kerckhofs G, Lambert F. Influence of induced infection in medication-related osteonecrosis of the jaw development after tooth extraction: A study in rats. J Craniomaxillofac Surg 2019; 47: 349-356.","DOI":"10.1016\/j.jcms.2018.08.011"},{"key":"6447_CR5087","doi-asserted-by":"crossref","unstructured":"Aguirre J I, Akhter M P, Kimmel D B et al. Oncologic doses of zoledronic acid induce osteonecrosis of the jaw-like lesions in rice rats (Oryzomys palustris) with periodontitis. J Bone Miner Res 2012; 27: 2130-2143.","DOI":"10.1002\/jbmr.1669"},{"key":"6447_CR5091","doi-asserted-by":"crossref","unstructured":"Otto S, Tr\u00f6ltzsch M, Jambrovic V et al. Tooth extraction in patients receiving oral or intravenous bisphosphonate administration: A trigger for BRONJ development? J Craniomaxillofac Surg 2015; 43: 847-854.","DOI":"10.1016\/j.jcms.2015.03.039"},{"key":"6447_CR5095","doi-asserted-by":"crossref","unstructured":"Saia G, Blandamura S, Bettini G et al. Occurrence of bisphosphonate-related osteonecrosis of the jaw after surgical tooth extraction. J Oral Maxillofac Surg 2010; 68: 797-804.","DOI":"10.1016\/j.joms.2009.10.026"},{"key":"6447_CR5101","doi-asserted-by":"crossref","unstructured":"Nicolatou-Galitis O, Papadopoulou E, Vardas E et al. Alveolar bone histological necrosis observed before extractions in patients, who received bone-targeting agents. Oral Dis 2020; 26: 955-966.","DOI":"10.1111\/odi.13294"},{"key":"6447_CR5105","doi-asserted-by":"crossref","unstructured":"Hadaya D, Soundia A, Gkouveris I, Dry S M, Aghaloo T L, Tetradis S. Development of Medication-Related Osteonecrosis of the Jaw After Extraction of Teeth With Experimental Periapical Disease. J Oral Maxillofac Surg 2019; 77: 71-86.","DOI":"10.1016\/j.joms.2018.08.010"},{"key":"6447_CR5113","doi-asserted-by":"crossref","unstructured":"Yarom N, Fedele S, Lazarovici T S, Elad S. Is exposure of the jawbone mandatory for establishing the diagnosis of bisphosphonate-related osteonecrosis of the jaw? J Oral Maxillofac Surg 2010; 68: 705.","DOI":"10.1016\/j.joms.2009.07.086"},{"key":"6447_CR5117","doi-asserted-by":"crossref","unstructured":"Bedogni A, Fedele S, Bedogni G et al. Staging of osteonecrosis of the jaw requires computed tomography for accurate definition of the extent of bony disease. Br J Oral Maxillofac Surg 2014; 52: 603-608.","DOI":"10.1016\/j.bjoms.2014.04.009"},{"key":"6447_CR5121","doi-asserted-by":"crossref","unstructured":"Ogura I, Minami Y, Ono J et al. CBCT imaging and histopathological characteristics of osteoradionecrosis and medication-related osteonecrosis of the jaw. Imaging Sci Dent 2021; 51: 73-80.","DOI":"10.5624\/isd.20200230"},{"key":"6447_CR5125","doi-asserted-by":"crossref","unstructured":"Badabaan G M, Singer S R, Creanga A G, Strickland M. Systematic review of cone beam computed tomography use in diagnosis of medication-related osteonecrosis of the jaw. Oral Surg Oral Med Oral Pathol Oral Radiol 2020; 130: 68-69.","DOI":"10.1016\/j.oooo.2020.03.032"},{"key":"6447_CR5129","doi-asserted-by":"crossref","unstructured":"Shimamoto H, Grogan T R, Tsujimoto T et al. Does CBCT alter the diagnostic thinking efficacy, management and prognosis of patients with suspected Stage 0 medication-related osteonecrosis of the jaws? Dentomaxillofac Radiol 2018; 47: 20170290.","DOI":"10.1259\/dmfr.20170290"}],"container-title":["British Dental Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41415-023-6447-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41415-023-6447-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41415-023-6447-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T09:07:42Z","timestamp":1700816862000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41415-023-6447-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,24]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,11,24]]}},"alternative-id":["6447"],"URL":"https:\/\/doi.org\/10.1038\/s41415-023-6447-8","relation":{},"ISSN":["0007-0610","1476-5373"],"issn-type":[{"value":"0007-0610","type":"print"},{"value":"1476-5373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,24]]},"assertion":[{"value":"14 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declaration"}},{"value":"Ethical approval and consent to participate was not required for this retrospective clinical case series.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declaration"}}]}}